iMicrobes
Latest round
- Seed
Last raised
- Nov 2024
Total raised
- $10M
Investors
- 2
About iMicrobes
, trading under the name iMicrobes, operates as a synthetic biology platform that converts greenhouse gases like methane and carbon dioxide into sustainable chemicals. The company was founded by Elizabeth Clarke, Derek Greenfield, and Noah Helman (CEO). iMicrobes engaged in the development of biobased materials utilizing programmable microbes that convert renewable feedstocks, specifically ethanol, and methane, into sustainable, net-zero chemical products. The company’s proprietary technology enables the production of low-carbon footprint acrylic acid precursors and other drop-in chemicals, catering to the increasing demand for sustainable bioproducts across various industries. iMicrobes serves a diverse client base, including manufacturers looking to replace petrochemical-derived materials with environmentally friendly alternatives. Their products are particularly focused on markets in North America and Europe, where there is a strong push for sustainable manufacturing practices and reduced environmental impact. iMicrobes generates revenue through partnerships and collaborations with commercial entities that seek to integrate sustainable materials into their supply chains. The company's revenue model is structured around co-developing biomanufacturing processes, providing clients with the microbial strains, bioprocesses, samples, and associated intellectual property necessary for production. The revenue transactions typically occur through long-term partnerships where clients pay for the development and licensing of the technology, enabling them to scale production while maintaining a focus on sustainability. The company aims to introduce new products aimed at enhancing the efficiency of biobased material production while targeting further penetration into North American and European markets by 2025.
Who invested in iMicrobes
2 investors across 1 round
See all investors in iMicrobes
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 19, 2024
Amount
$10M
Investors
Questions about iMicrobes
Who invested in iMicrobes?
iMicrobes has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iMicrobes raised?
iMicrobes has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did iMicrobes last raise money?
iMicrobes's most recent round on record is a Seed, in Nov 2024.
What does iMicrobes do?
, trading under the name iMicrobes, operates as a synthetic biology platform that converts greenhouse gases like methane and carbon dioxide into sustainable chemicals.
Where is iMicrobes headquartered?
iMicrobes is headquartered in Alameda, US.
Which VCs invest in companies like iMicrobes?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back environmental services companies at iMicrobes's stage. Their profiles are linked below.
VCs backing environmental services startups at Seed
Raising like iMicrobes? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.